Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Grape Seed Extract
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Hemodynamic Effects of a Standardized Grape Seed Extract Supplementation
Details : Grape Seed Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Prehypertension.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
July 29, 2025
Lead Product(s) : Grape Seed Extract
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Grape Seed Extract
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults
Details : Grape Seed Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
June 03, 2024
Lead Product(s) : Grape Seed Extract
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Grape Seed Extract
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Grape Seed Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Glucose Intolerance.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
October 01, 2014
Lead Product(s) : Grape Seed Extract
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable